Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.

Citrome L, Reist C, Palmer L, Montejano L, Lenhart G, Cuffel B, Harnett J, Sanders KN.

Schizophr Res. 2009 Mar;108(1-3):238-44. doi: 10.1016/j.schres.2008.11.017. Epub 2008 Dec 23.

PMID:
19106035
[PubMed - indexed for MEDLINE]
2.

Impact of real-world ziprasidone dosing on treatment discontinuation rates in patients with schizophrenia or bipolar disorder.

Citrome L, Reist C, Palmer L, Montejano LB, Lenhart G, Cuffel B, Harnett J, Sanders KN.

Schizophr Res. 2009 Dec;115(2-3):115-20. doi: 10.1016/j.schres.2009.09.023. Epub 2009 Oct 27.

PMID:
19864113
[PubMed - indexed for MEDLINE]
3.

Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.

Kim E, Maclean R, Ammerman D, Jing Y, Pikalov A, You M, Van-Tran Q, L'Italien G.

Clin Ther. 2009 Apr;31(4):836-48. doi: 10.1016/j.clinthera.2009.04.022.

PMID:
19446157
[PubMed - indexed for MEDLINE]
4.

Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.

Rascati KL, Richards KM, Ott CA, Goddard AW, Stafkey-Mailey D, Alvir J, Sanders KN, Mychaskiw M.

Psychiatr Serv. 2011 Sep;62(9):1032-40. doi: 10.1176/appi.ps.62.9.1032.

PMID:
21885581
[PubMed - indexed for MEDLINE]
5.

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.

Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T.

J Med Econ. 2011;14(6):777-86. doi: 10.3111/13696998.2011.625066. Epub 2011 Sep 29.

PMID:
21954966
[PubMed - indexed for MEDLINE]
6.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

PMID:
14994733
[PubMed - indexed for MEDLINE]
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
[PubMed - indexed for MEDLINE]
8.

Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

Greenberg WM, Citrome L.

CNS Drug Rev. 2007 Summer;13(2):137-77. Review.

PMID:
17627670
[PubMed - indexed for MEDLINE]
9.

Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.

Van Dorn RA, Andel R, Boaz TL, Desmarais SL, Chandler K, Becker MA, Howe A.

J Clin Psychiatry. 2011 Apr;72(4):502-8. doi: 10.4088/JCP.10m06618.

PMID:
21527125
[PubMed - indexed for MEDLINE]
10.

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H.

Curr Med Res Opin. 2007 Nov;23(11):2805-14.

PMID:
17910804
[PubMed - indexed for MEDLINE]
11.

Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.

Edwards SJ, Smith CJ.

Clin Ther. 2009 Jun;31 Pt 1:1345-59. doi: 10.1016/j.clinthera.2009.07.004. Review.

PMID:
19698898
[PubMed - indexed for MEDLINE]
12.

Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST).

Boter H, Peuskens J, Libiger J, Fleischhacker WW, Davidson M, Galderisi S, Kahn RS; EUFEST study group.

Schizophr Res. 2009 Dec;115(2-3):97-103. doi: 10.1016/j.schres.2009.09.019. Epub 2009 Oct 9.

PMID:
19819114
[PubMed - indexed for MEDLINE]
13.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Newcomer JW.

CNS Drugs. 2005;19 Suppl 1:1-93. Review.

PMID:
15998156
[PubMed - indexed for MEDLINE]
14.

Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.

Gianfrancesco F, Pesa J, Wang RH.

J Manag Care Pharm. 2005 Apr;11(3):220-30.

PMID:
15804206
[PubMed - indexed for MEDLINE]
Free Article
15.

Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.

Citrome L, Yang R, Glue P, Karayal ON.

Schizophr Res. 2009 Jun;111(1-3):39-45. doi: 10.1016/j.schres.2009.03.009. Epub 2009 Apr 17.

PMID:
19375893
[PubMed - indexed for MEDLINE]
16.

Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.

Citrome L, Kalsekar I, Guo Z, Laubmeier K, Hebden T.

Clin Ther. 2013 Dec;35(12):1867-75. doi: 10.1016/j.clinthera.2013.09.006. Epub 2013 Oct 8.

PMID:
24119767
[PubMed - indexed for MEDLINE]
Free Article
17.

Quality of life in the long-term treatment and the role of second-generation antipsychotics.

Mohr P.

Neuro Endocrinol Lett. 2007 Feb;28 Suppl 1:117-33. Review.

PMID:
17262004
[PubMed - indexed for MEDLINE]
18.

Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.

Hassan M, Madhavan SS, Kalsekar ID, Makela EH, Rajagopalan K, Islam S, Kavookjian J, Miller LA.

Ann Pharmacother. 2007 Nov;41(11):1812-8. Epub 2007 Oct 9.

PMID:
17925501
[PubMed - indexed for MEDLINE]
19.

The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder.

Gianfrancesco FD, Sajatovic M, Rajagopalan K, Wang RH.

Int Clin Psychopharmacol. 2008 Nov;23(6):305-16. doi: 10.1097/YIC.0b013e32830b0f88.

PMID:
18854718
[PubMed - indexed for MEDLINE]
20.

Weight effects associated with antipsychotics: a comprehensive database analysis.

Parsons B, Allison DB, Loebel A, Williams K, Giller E, Romano S, Siu C.

Schizophr Res. 2009 May;110(1-3):103-10. doi: 10.1016/j.schres.2008.09.025. Epub 2009 Mar 24.

PMID:
19321312
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk